Law Firm Newsletters: Roundup

Law firms routinely post articles, newsletters, client alerts, etc. to their web sites.  Many are thinly-disguised teasers, telling just enough to interest clients (and potential clients) and giving a handy phone number that will connect the reader to a willing associate or partner who will gladly expound and expand on the published comments for no more than $500 per hour.  That said, they are occasionally a good source of information on developments deemed by health lawyers to be worthy of comment and fair warning.

That said, I offer herewith a quick overview of some of the more useful postings by these ready-to-please health lawyers, in no particular order of significance:

• Interim Reports To The 79th Texas Legislature: V&E Preliminary Picks For Principal Health-Related Legislative Plays.  (Vinson & Elkins)
• SNF Consolidated Billing Revisited: CMS issues new instructions in an effort to clear up confusion over consolidated billing requirements for Part A Medicare patients.  (Epstein, Becker & Green; PDF)
• Parallel Trade in the EU and US Pharmaceutical Markets.  (Arnold & Porter; PDF)
• The New Form 1023: What Does It Mean for Charitable Organizations? (McDermott, Will & Emory)
• What to Do When Facing Peer Review.  (Epstein, Becker & Green; PDF)
• Medicines for Children: Parts I & II (Arnold & Porter; PDF)
• Medicare Prospective Payment System for Inpatient Psychiatric Hospitals and Units (McDermott, Will & Emory)
• Legal and Scientific Considerations in Nonclinical Assessment of Biotechnology Products.  (Arnold & Porter; PDF)
• New California Law Requires Pharmaceutical Companies to Adopt Comprehensive Compliance Programs in Accordance with OIG Guidance and PhRMA Code. (Epstein, Becker & Green)